{
  "url": "https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.35/division-2",
  "json_url": "https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.35/division-2.json",
  "legislation": "eudn/2018/945",
  "legislation_title": "Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-decision-2018-945",
  "path": "annex/II/division/3/division/3.35/division/2",
  "kind": "division",
  "number": null,
  "heading": "Laboratory Criteria",
  "text": "At least one of the following four:\nIsolation of Lyssa virus from a clinical specimen\nDetection of Lyssa virus nucleic acid in a clinical specimen (for example, saliva or brain tissue)\nDetection of viral antigens by a DFA in a clinical specimen\nLyssa virus specific antibody response by virus neutralization assay in serum or CSF\nLaboratory results need to be interpreted according to the vaccination or immunization status",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/3/division/3.35/division/2",
    "retrieved_at": "2026-11-01T15:13:03.598650+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}